Source:http://linkedlifedata.com/resource/pubmed/id/18485840
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0025663,
umls-concept:C0032105,
umls-concept:C0039789,
umls-concept:C0064113,
umls-concept:C0086418,
umls-concept:C0185125,
umls-concept:C0205250,
umls-concept:C0249851,
umls-concept:C0332324,
umls-concept:C0521115,
umls-concept:C1516801,
umls-concept:C1519941,
umls-concept:C1527148,
umls-concept:C1709793,
umls-concept:C2603343
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
2008-6-3
|
pubmed:abstractText |
A highly sensitive and specific LC-MS/MS method has been developed for simultaneous estimation of itraconazole (ITZ) and hydroxyitraconazole (OH-ITZ) with 500 microL of human plasma using fluconazole as an internal standard (IS). The API-4000 LC-MS/MS was operated under the multiple reaction-monitoring mode (MRM) using the electrospray ionization technique. Solid phase extraction process was used to extract ITZ, OH-ITZ and IS from human plasma. The total run time was 3.0 min and the elution of ITZ, OH-ITZ and IS occurred at 2.08 min, 1.85 min and 1.29 min, respectively; this was achieved with a mobile phase consisting of 0.2% (v/v) ammonia solution:acetonitrile (20:80, v/v) at a flow rate of 0.50 mL/min on a HyPurity C(18) (50 mm x 4.6 mm, 5 microm) column. The developed method was validated in human plasma with a lower limit of quantitation of 0.50 ng/mL for both ITZ and OH-ITZ. A linear response function was established for the range of concentrations 0.5-263 ng/mL (r>0.998) for both ITZ and OH-ITZ. The intra- and inter-day precision values for ITZ and OH-ITZ met the acceptance as per FDA guidelines. ITZ and OH-ITZ were stable in the battery of stability studies, viz., bench-top, auto-sampler, dry extract and freeze/thaw cycles. The developed assay method was applied to an oral bioequivalence study in humans.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1570-0232
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
868
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
70-6
|
pubmed:meshHeading |
pubmed-meshheading:18485840-Chromatography, Liquid,
pubmed-meshheading:18485840-Humans,
pubmed-meshheading:18485840-Itraconazole,
pubmed-meshheading:18485840-Reproducibility of Results,
pubmed-meshheading:18485840-Sensitivity and Specificity,
pubmed-meshheading:18485840-Spectrometry, Mass, Electrospray Ionization,
pubmed-meshheading:18485840-Tandem Mass Spectrometry,
pubmed-meshheading:18485840-Therapeutic Equivalency
|
pubmed:year |
2008
|
pubmed:articleTitle |
Development and validation of a highly sensitive and robust LC-MS/MS with electrospray ionization method for simultaneous quantitation of itraconazole and hydroxyitraconazole in human plasma: application to a bioequivalence study.
|
pubmed:affiliation |
Department of Chemistry, Jawaharlal Nehru Technological University Kukatpally, Hyderabad, India.
|
pubmed:publicationType |
Journal Article,
Validation Studies
|